Investigator

Clinical research site in Chattanooga, Tennessee · Metro Service Agency, 736 Market St, Chattanooga, TN 37402 · (423) 645-7888 · Website

As of July 2026, 1 paid clinical trial is recruiting at Investigator in Chattanooga, Tennessee. Active studies at this site focus on Focal Segmental Glomerulosclerosis alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Investigator (1)

A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

for Focal Segmental Glomerulosclerosis

22 locations incl. Chula Vista

Sponsor: Akebia Therapeutics

Sex: All·Age: 18+

Code: NCT07268638·Phase 2·Recruiting·Listed Dec 2025

Apply to this trial

More research sites in Chattanooga

Southeast Renal Research Institute (5 trials)
T C Thompson Children's Hospital (5 trials)
GSK Investigational Site (4 trials)
Tennessee Oncology, PLLC - Chattanooga Downtown (4 trials)
Tennessee Oncology, PLLC - Chattanooga Med Park II (4 trials)
Tennessee Oncology, PLLC - Chattanooga Memorial (4 trials)
Erlanger Health System (4 trials)
ClinSearch, LLC (3 trials)
Erlanger Health, Inc. (3 trials)
Tennessee Oncology (3 trials)

Explore more

Paid clinical trials in Chattanooga, TN · Tennessee clinical trials